Professor of Clinical Neuropsychology, University of Cambridge
Barbara Sahakian's research is aimed at understanding the neural basis of cognitive, emotional and behavioural dysfunction in order to develop more effective pharmacological and psychological treatments. The focus of my lab is on early detection, differential diagnosis and proof of concept studies using cognitive enhancing drugs. She is President of the International Neuroethics Society.
LSD 'microdosing' is trending in Silicon Valley
Feb 16, 2017 08:21 am UTC| Insights & Views Health
It may seem like a doomed attempt to mix business and pleasure. But a growing number of young professionals in Silicon Valley insist that taking small doses of psychedelic drugs simply makes them perform better at work ...
The science, drugs and tech pushing our brains to new limits
Oct 04, 2016 12:57 pm UTC| Science
A recent explosion of neuroscience techniques is driving substantial advances in our understanding of the brain. Combined with developments in engineering, machine learning and computing this flowering has helped us...
Fair play? How 'smart drugs' are making workplaces more competitive
Jul 03, 2016 02:45 am UTC| Insights & Views Life Health
We live in an increasingly competitive world where we are always looking to gain an advantage over our rivals, sometimes even our own colleagues. In some cases, it can push people to extreme, unethical and illegitimate...